HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of bullous keratopathy-related ulcer with autologous serum.

AbstractPURPOSE:
The aim of this study was to report the use of autologous serum eyedrops (ASEs) for resolution of a corneal ulcer secondary to bullous keratopathy.
METHODS:
This is a case report.
RESULTS:
A 66-year-old patient presented with an infected ulcer and hypopyon while using a bandage contact lens for bullous keratopathy. Staphylococcus warneri infection was treated with systemic and topical antibiotics, and ASEs were subsequently administered to enhance reepithelialization and to avoid the need for a bandage contact lens. The ASE treatment led to closure of the epithelium layer within 3 weeks, and it was subsequently tapered over the next 3 months. The clinical picture remained stable subjectively and objectively during the 7 months of follow-up.
DISCUSSION:
To the best of our knowledge, this is the first report of successful use of ASEs in treating and preventing recurrence of ulcers in the context of bullous keratopathy.
AuthorsAsimina Mataftsi, Areti Bourtoulamaiou, Konstantinos Anastasilakis, Nikolaos G Ziakas, Stavros A Dimitrakos
JournalEye & contact lens (Eye Contact Lens) Vol. 39 Issue 4 Pg. e19-20 (Jul 2013) ISSN: 1542-233X [Electronic] United States
PMID22781466 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ophthalmic Solutions
Topics
  • Aged
  • Corneal Diseases (complications, therapy)
  • Corneal Ulcer (etiology, therapy)
  • Eye Infections, Bacterial (complications)
  • Female
  • Humans
  • Ophthalmic Solutions (therapeutic use)
  • Serum
  • Staphylococcal Infections (complications)
  • Transplantation, Autologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: